GW Henssler & Associates Ltd. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 21,102 shares of the biopharmaceutical company’s stock after selling 190 shares during the period. GW Henssler & Associates Ltd.’s […]
Eudaimonia Advisors LLC trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 879 shares of the biopharmaceutical company’s stock after selling 20 shares during the quarter. Eudaimonia Advisors […]
Sterling Investment Advisors Ltd. grew its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,752 shares of the biopharmaceutical company’s stock after acquiring an additional 319 shares during […]
Asset Management One Co. Ltd. grew its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,365 shares of the biopharmaceutical company’s stock after buying an additional 771 shares during the quarter. Asset Management […]
Ledyard National Bank reduced its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,031 shares of the biopharmaceutical company’s stock after selling 336 shares during the period. […]